Edronax is an antidepressant drug used in the treatment of clinical depression, panic disorder and ADD/ADHD. Its mesylate (i.e. methanesulfonate) salt is sold under tradenames including Edronax, Norebox, Prolift, Solvex, Davedax or Vestra. Edronax has two chiral centers, but it only exists as two enantiomers, (R,R)-(-)- and (S,S)-(+)-reboxetine.

Edronax - Pharmacology:

Edronax is a selective inhibitor of noradrenaline reuptake. It inhibits
noradrenaline reuptake in vitro to a similar extent to the tricyclic
antidepressant desmethylimipramine. Edronax does not affect dopamine or
serotonin reuptake and it has low in vivo and in vitro affinity
for adrenergic, cholinergic, histaminergic, dopaminergic and serotonergic

Edronax Interactions

Combined usage of MAO inhibitors should be avoided

Edronax Contraindications

Caution is recommended in patients with evidence of urinary retention and glaucoma

Generic name, Overdose, Half Life Edronax, Food Interactions, Chemical, etc..

Edronax see also

Brand Names containing Reboxetine

Chemical structure:
N O O O H H H H H H H H H H H H H H H H H H H H H H H C19H23NO3 2D chemical structure C19H23NO3 SVG | 2D structure Reboxetine | Ethylmorphine | chemical names, chemical properties, classification C19H23NO3